Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F16%3A00011283" target="_blank" >RIV/75010330:_____/16:00011283 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/16:43911203
Result on the web
<a href="http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-2958-4" target="_blank" >http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-2958-4</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s12889-016-2958-4" target="_blank" >10.1186/s12889-016-2958-4</a>
Alternative languages
Result language
angličtina
Original language name
Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012
Original language description
In the Czech Republic, two-dose immunization against mumps achieves 98 % coverage. The routine reporting detects mumps cases, clinical complications, and hospital admissions in unvaccinated but also in vaccinated individuals. Using surveillance data of patients with mumps we assessed the effectiveness of mumps vaccination on mumps clinical complications and hospitalization need. We also investigated the effect of the time since immunization. We analysed data on incident mumps cases reported to the Czech national surveillance system in 2007-2012. Results: From total of 9663 mumps analysed cases 5600 (58 %) occurred in males. The mean age at the disease onset was 17.3, median 16 years. Ninety percent of the study patients had no complications, while 1.6 % developed meningitis, 0.2 % encephalitis, and 0.6 % pancreatitis. Mumps orchitis occurred in 659 (11.8 %) male cases. In total, 1192 (12.3 %) patients required hospitalization. Two doses of vaccine received by 81.8 % cases significantly reduced the risk of hospitalization. This study demonstrates a significant preventive effect of two-dose vaccination against mumps complications (orchitis, meningitis, or encephalitis) and hospitalization for mumps. The risk of complications increases with time interval from vaccination. Teenagers and young adults were the most affected age groups.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FN - Epidemiology, infection diseases and clinical immunology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT14059" target="_blank" >NT14059: Clinically manifest mumps in the vaccinated population – genotyping of the causative virus and patient’s serological profile.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
BMC Public Health
ISSN
1471-2458
e-ISSN
—
Volume of the periodical
16
Issue of the periodical within the volume
April
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
—
UT code for WoS article
000373257600002
EID of the result in the Scopus database
—